Ernest H. Choy

Cardiff, WLS, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 229 publications

Efficacy, safety, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab intravenously administered to adults with active rheumatoid arthritis and an inadequate response to methotrexate: a phase 3, randomised study.

Efficacy, safety, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab intravenously administered to adults with active rheumatoid arthritis and an inadequate response to methotrexate: a phase 3, randomised study.

Journal: EULAR rheumatology open

Published: June 29, 2026

Comparison of the PK, PD, safety, tolerability, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab in healthy Japanese males: a phase 1, randomised, crossover study.

Comparison of the PK, PD, safety, tolerability, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab in healthy Japanese males: a phase 1, randomised, crossover study.

Journal: EULAR rheumatology open

Published: June 29, 2026

Interleukin-6 stimulates platelet 12-lipoxygenase to drive coagulation in inflammatory arthritis.

Interleukin-6 stimulates platelet 12-lipoxygenase to drive coagulation in inflammatory arthritis.

Journal: Journal of lipid research

Published: May 29, 2026

Phenotypic Factors and Celecoxib Efficacy in Knee OA: A Post‑hoc Pooled Analysis of Two Randomized, Double‑Blind, Placebo‑Controlled Trials.

Phenotypic Factors and Celecoxib Efficacy in Knee OA: A Post‑hoc Pooled Analysis of Two Randomized, Double‑Blind, Placebo‑Controlled Trials.

Journal: Pain and therapy

Published: May 04, 2026

Understanding patient and physician global assessments in rheumatoid arthritis: A meta-epidemiological study of core outcome set performance.

Understanding patient and physician global assessments in rheumatoid arthritis: A meta-epidemiological study of core outcome set performance.

Journal: Seminars in arthritis and rheumatism

Published: April 04, 2026

Dermatomyositis mortality by myositis-specific autoantibodies: A systematic review and meta-analysis.

Dermatomyositis mortality by myositis-specific autoantibodies: A systematic review and meta-analysis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: March 06, 2026

Publisher Correction: Interpretable inflammation landscape of circulating immune cells.

Publisher Correction: Interpretable inflammation landscape of circulating immune cells.

Journal: Nature medicine

Published: January 26, 2026

Serum Autoantibodies in Dermatomyositis and Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.

Serum Autoantibodies in Dermatomyositis and Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.

Journal: Journal of cutaneous medicine and surgery

Published: December 18, 2025

Changes in bone mineral density and fractures during 2 years of low-dose glucocorticoid treatment for rheumatoid arthritis: a systematic literature review and individual participant data meta-analysis.

Changes in bone mineral density and fractures during 2 years of low-dose glucocorticoid treatment for rheumatoid arthritis: a systematic literature review and individual participant data meta-analysis.

Journal: RMD open

Published: December 08, 2025

Different dosing regimens for chronic knee osteoarthritis (KOA) pain management: A pooled analysis on celecoxib.

Different dosing regimens for chronic knee osteoarthritis (KOA) pain management: A pooled analysis on celecoxib.

Journal: Aging clinical and experimental research

Published: December 03, 2025

Decision on Optimal Combinatorial Therapies in Immune-mediated inflammatory diseases using Systems approaches (DocTIS): protocol for a single-arm, adaptive basket trial in rheumatoid and psoriatic arthritis.

Decision on Optimal Combinatorial Therapies in Immune-mediated inflammatory diseases using Systems approaches (DocTIS): protocol for a single-arm, adaptive basket trial in rheumatoid and psoriatic arthritis.

Journal: Rheumatology advances in practice

Published: November 03, 2025

Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.

Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.

Journal: Seminars in arthritis and rheumatism

Published: October 15, 2025

Showing 1-12 of 229

Last Updated: 09/26/2026